These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33111857)

  • 1. Patients' Preferences after Recurrent Coronary Narrowing: Discrete Choice Experiments.
    Magliano CADS; Monteiro AL; Rebelo ARO; Santos GF; Pereira CCA; Krucien N; Saraiva RM
    Arq Bras Cardiol; 2020 Oct; 115(4):613-619. PubMed ID: 33111857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-vignette based assessment of patient's perspective on coronary revascularization strategies, the OPINION study.
    Masdjedi K; Daemen J; Diletti R; Wilschut J; Utens E; de Jaegere PP; Lemmert ME; Kappetein AP; Zijlstra F; van Domburg R; Van Mieghem NM
    J Cardiol; 2018 Aug; 72(2):149-154. PubMed ID: 29478878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
    Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].
    Liu R; Jiang L; Xu LJ; Tian J; Zhao XY; Zhang Y; Xu JJ; Song Y; Wang HH; Gao Z; Song L; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1049-1057. PubMed ID: 29325365
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention vs. coronary artery bypass grafting for left main revascularization: an updated meta-analysis.
    Bajaj NS; Patel N; Kalra R; Marogil P; Bhardwaj A; Arora G; Arora P
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):173-182. PubMed ID: 28838092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease.
    Nyström T; Sartipy U; Franzén S; Eliasson B; Gudbjörnsdottir S; Miftaraj M; Lagerqvist B; Svensson AM; Holzmann MJ
    J Am Coll Cardiol; 2017 Sep; 70(12):1441-1451. PubMed ID: 28851544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcomes of patients with unprotected left main coronary artery disease post revascularization].
    Yu X; Lyu S; He J; Gao Y; Luo Y; Song X; Yuan F; Huang F; Gu C; Chen F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 May; 43(5):399-403. PubMed ID: 26419983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in triple-vessel disease: Hybrid coronary revascularization compared to contemporary revascularization methods.
    Basman C; Hemli JM; Kim MC; Seetharam K; Brinster DR; Pirelli L; Kliger CA; Scheinerman SJ; Singh VP; Patel NC
    J Card Surg; 2020 Oct; 35(10):2710-2718. PubMed ID: 32725629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
    Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus.
    Li Y; Dong R; Hua K; Liu TS; Zhou SY; Zhou N; Zhang HJ
    Chin Med J (Engl); 2017 Dec; 130(24):2906-2915. PubMed ID: 29237922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.